Reaffirmed: LifePoint Health (NASDAQ:LPNT) “Buy” Rating Reconfirmed by Leerink Swann; $58.0 Target in Place

January 21, 2018 - By Vivian Park

 Reaffirmed: LifePoint Health (NASDAQ:LPNT)

Investors sentiment increased to 1.3 in 2017 Q3. Its up 0.12, from 1.18 in 2017Q2. It is positive, as 19 investors sold LifePoint Health, Inc. shares while 61 reduced holdings. 31 funds opened positions while 73 raised stakes. 40.50 million shares or 0.54% more from 40.28 million shares in 2017Q2 were reported.

Geode Mngmt Ltd Com stated it has 0.01% of its portfolio in LifePoint Health, Inc. (NASDAQ:LPNT). 8,900 were accumulated by Highland Management Lp. Stevens Cap Mngmt Ltd Partnership invested 0.05% of its portfolio in LifePoint Health, Inc. (NASDAQ:LPNT). State Of Wisconsin Board has 0% invested in LifePoint Health, Inc. (NASDAQ:LPNT) for 7,573 shares. Jarislowsky Fraser Limited invested in 69,200 shares. Comerica Savings Bank holds 0.01% or 31,264 shares. Credit Suisse Ag owns 59,358 shares. Robeco Institutional Asset Bv invested in 42,234 shares or 0.02% of the stock. Canada Pension Plan Inv Board accumulated 0% or 20,500 shares. Wellington Grp Llp, a Massachusetts-based fund reported 3.40 million shares. Smith Graham And Commerce Inv Advisors L P has 0.73% invested in LifePoint Health, Inc. (NASDAQ:LPNT). Thrivent Finance For Lutherans invested in 0.01% or 25,898 shares. Eaton Vance Mgmt stated it has 49,097 shares or 0.01% of all its holdings. New York-based Jefferies Grp Ltd Liability has invested 0% in LifePoint Health, Inc. (NASDAQ:LPNT). State Treasurer State Of Michigan reported 15,100 shares.

LifePoint Health (NASDAQ:LPNT) Rating Reaffirmed

LifePoint Health (NASDAQ:LPNT) just had their share rating of a ‘”Buy”‘ issued by research analysts at Leerink Swann, who now has a $58.0 PT on the $1.90B market cap company or a 20.21 % upside potential. This key information was revealed to clients and investors in analysts report on Tuesday, 31 October.

Investors sentiment increased to 1.3 in 2017 Q3. Its up 0.12, from 1.18 in 2017Q2. It is positive, as 19 investors sold LifePoint Health, Inc. shares while 61 reduced holdings. 31 funds opened positions while 73 raised stakes. 40.50 million shares or 0.54% more from 40.28 million shares in 2017Q2 were reported.

Geode Mngmt Ltd Com stated it has 0.01% of its portfolio in LifePoint Health, Inc. (NASDAQ:LPNT). 8,900 were accumulated by Highland Management Lp. Stevens Cap Mngmt Ltd Partnership invested 0.05% of its portfolio in LifePoint Health, Inc. (NASDAQ:LPNT). State Of Wisconsin Board has 0% invested in LifePoint Health, Inc. (NASDAQ:LPNT) for 7,573 shares. Jarislowsky Fraser Limited invested in 69,200 shares. Comerica Savings Bank holds 0.01% or 31,264 shares. Credit Suisse Ag owns 59,358 shares. Robeco Institutional Asset Bv invested in 42,234 shares or 0.02% of the stock. Canada Pension Plan Inv Board accumulated 0% or 20,500 shares. Wellington Grp Llp, a Massachusetts-based fund reported 3.40 million shares. Smith Graham And Commerce Inv Advisors L P has 0.73% invested in LifePoint Health, Inc. (NASDAQ:LPNT). Thrivent Finance For Lutherans invested in 0.01% or 25,898 shares. Eaton Vance Mgmt stated it has 49,097 shares or 0.01% of all its holdings. New York-based Jefferies Grp Ltd Liability has invested 0% in LifePoint Health, Inc. (NASDAQ:LPNT). State Treasurer State Of Michigan reported 15,100 shares.

LifePoint Health, Inc. (NASDAQ:LPNT) Ratings Coverage

Among 22 analysts covering Lifepoint Hospitals (NASDAQ:LPNT), 4 have Buy rating, 3 Sell and 15 Hold. Therefore 18% are positive. Lifepoint Hospitals has $107 highest and $45 lowest target. $64.68’s average target is 34.05% above currents $48.25 stock price. Lifepoint Hospitals had 53 analyst reports since August 4, 2015 according to SRatingsIntel. Leerink Swann upgraded the shares of LPNT in report on Wednesday, June 7 to “Outperform” rating. The firm has “Buy” rating by Citigroup given on Monday, June 6. On Friday, October 2 the stock rating was initiated by Citigroup with “Buy”. The rating was maintained by RBC Capital Markets on Monday, October 9 with “Buy”. The firm has “Buy” rating given on Wednesday, July 5 by RBC Capital Markets. The rating was maintained by BMO Capital Markets on Monday, October 30 with “Market Perform”. The rating was maintained by Leerink Swann on Tuesday, October 31 with “Outperform”. The firm has “Hold” rating given on Friday, October 27 by Mizuho. The company was maintained on Monday, May 2 by Barclays Capital. The firm has “Hold” rating by SunTrust given on Friday, October 13.

The stock decreased 0.92% or $0.45 during the last trading session, reaching $48.25. About 750,023 shares traded or 35.73% up from the average. LifePoint Health, Inc. (NASDAQ:LPNT) has declined 5.01% since January 21, 2017 and is downtrending. It has underperformed by 21.71% the S&P500.

Analysts await LifePoint Health, Inc. (NASDAQ:LPNT) to report earnings on February, 16. They expect $0.82 earnings per share, down 24.77 % or $0.27 from last year’s $1.09 per share. LPNT’s profit will be $32.32M for 14.71 P/E if the $0.82 EPS becomes a reality. After $0.80 actual earnings per share reported by LifePoint Health, Inc. for the previous quarter, Wall Street now forecasts 2.50 % EPS growth.

LifePoint Health, Inc., through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers, and post-acute facilities in the United States. The company has market cap of $1.90 billion. The Company’s hospitals offer a range of medical and surgical services, such as general surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, rehabilitation, and pediatric services, as well as specialized services, including open-heart surgery, skilled nursing, psychiatric care, and neuro-surgery. It has a 11.43 P/E ratio. The companyÂ’s hospitals also provide various outpatient services comprising same-day surgery, laboratory, X-ray, respiratory therapy, imaging, sports medicine, and lithotripsy.

More important recent LifePoint Health, Inc. (NASDAQ:LPNT) news were published by: Businesswire.com which released: “Annual JP Morgan Healthcare Conference” on January 02, 2018, also Seekingalpha.com published article titled: “LifePoint Health’s (LPNT) CEO William Carpenter on Q3 2017 Results – Earnings …”, Businesswire.com published: “LifePoint Health Reports Third Quarter 2017 Results” on October 27, 2017. More interesting news about LifePoint Health, Inc. (NASDAQ:LPNT) was released by: Seekingalpha.com and their article: “LifePoint Health (LPNT) Q2 2017 Results – Earnings Call Transcript” with publication date: August 01, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.